|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
|
|---|---|---|---|
| ASSETS | |||
| Current assets | |||
| Cash | |||
| Cash and cash equivalents | |||
| Restricted cash | |||
| Accounts receivable, net | |||
| Other receivable | |||
| Related Party | |||
| Nonrelated Party | |||
| Investment in preferred equity | |||
| Derivative asset | |||
| Security deposit | |||
| Inventory, net | |||
| Other current assets | |||
| Total current assets | |||
| Land | |||
| Construction in progress | |||
| Property, plant and equipment | |||
| TOTAL ASSETS | |||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||
| Current liabilities | |||
| Accounts payable | |||
| Related party payable | |||
| Interest payable | |||
| Professional fees payable | |||
| Loan payable to related party | |||
| Notes payable, current portion | |||
| Related Party | |||
| Nonrelated Party | |||
| Total notes payable, current portion | |||
| Convertible note payable to related party | |||
| Accrued expenses and other current liabilities | |||
| Total current liabilities | |||
| Financial liability, net of closing costs | |||
| TOTAL LIABILITIES | |||
| STOCKHOLDERS’ EQUITY | |||
| Common stock; $0.001 par value, 900,000,000 shares authorized; 1 and 140,227,818 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | |||
| Subscription receivable | |||
| Additional paid-in capital | |||
| Accumulated deficit | |||
| TOTAL STOCKHOLDERS’ EQUITY | |||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
Loading...
